Cargando…

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters

p27 is regarded as a cyclin-dependent kinase inhibitor of the G1-to-S cell cycle progression by suppressing the kinase activity of cyclin/cyclin-dependent kinase complex. This study aimed to investigate p27 expression in the normal endometrium and endometrioid adenocarcinoma of the uterine corpus an...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, J, Sato, H, Kanai, T, Kamata, Y, Jobo, T, Hata, H, Fujisawa, T, Ohno, E, Kameya, T, Kuramoto, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364278/
https://www.ncbi.nlm.nih.gov/pubmed/12085261
http://dx.doi.org/10.1038/sj.bjc.6600434
_version_ 1782153914789920768
author Watanabe, J
Sato, H
Kanai, T
Kamata, Y
Jobo, T
Hata, H
Fujisawa, T
Ohno, E
Kameya, T
Kuramoto, H
author_facet Watanabe, J
Sato, H
Kanai, T
Kamata, Y
Jobo, T
Hata, H
Fujisawa, T
Ohno, E
Kameya, T
Kuramoto, H
author_sort Watanabe, J
collection PubMed
description p27 is regarded as a cyclin-dependent kinase inhibitor of the G1-to-S cell cycle progression by suppressing the kinase activity of cyclin/cyclin-dependent kinase complex. This study aimed to investigate p27 expression in the normal endometrium and endometrioid adenocarcinoma of the uterine corpus and the correlation of its expression with cell proliferation and clinicopathological parameters. Tissue samples of 127 endometrioid adenocarcinomas and 15 normal endometria were used in the study. Immunohistochemical staining for detecting p27 and Ki-67 was performed by the labelled streptavidin-biotin method on formalin-fixed and paraffin-embedded tissue samples. The expression was given as the labelling index, which indicates the percentage of positive nuclei. p27 staining was observed in the nuclei of the glandular cells in the functional layer of the secretory phase endometrium, whereas it was negative in those of the proliferative phase. In endometrioid adenocarcinomas, the labelling index of p27 expression paradoxically increased more significantly in the higher histological grades and was correlated with that of Ki-67. The high level of p27 expression was associated with clinicopathological parameters such as FIGO stage, lymph node metastasis, lymphovascular space involvement and myometrial invasion. High p27 expression was linked to higher grades of endometrioid adenocarcinoma, cell proliferation and some clinical prognostic factors. These results indicate that p27 might be an indicator of poor prognosis. British Journal of Cancer (2002) 87, 81–85. doi:10.1038/sj.bjc.6600434 www.bjcancer.com © 2002 Cancer Research UK
format Text
id pubmed-2364278
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23642782009-09-10 Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters Watanabe, J Sato, H Kanai, T Kamata, Y Jobo, T Hata, H Fujisawa, T Ohno, E Kameya, T Kuramoto, H Br J Cancer Molecular and Cellular Pathology p27 is regarded as a cyclin-dependent kinase inhibitor of the G1-to-S cell cycle progression by suppressing the kinase activity of cyclin/cyclin-dependent kinase complex. This study aimed to investigate p27 expression in the normal endometrium and endometrioid adenocarcinoma of the uterine corpus and the correlation of its expression with cell proliferation and clinicopathological parameters. Tissue samples of 127 endometrioid adenocarcinomas and 15 normal endometria were used in the study. Immunohistochemical staining for detecting p27 and Ki-67 was performed by the labelled streptavidin-biotin method on formalin-fixed and paraffin-embedded tissue samples. The expression was given as the labelling index, which indicates the percentage of positive nuclei. p27 staining was observed in the nuclei of the glandular cells in the functional layer of the secretory phase endometrium, whereas it was negative in those of the proliferative phase. In endometrioid adenocarcinomas, the labelling index of p27 expression paradoxically increased more significantly in the higher histological grades and was correlated with that of Ki-67. The high level of p27 expression was associated with clinicopathological parameters such as FIGO stage, lymph node metastasis, lymphovascular space involvement and myometrial invasion. High p27 expression was linked to higher grades of endometrioid adenocarcinoma, cell proliferation and some clinical prognostic factors. These results indicate that p27 might be an indicator of poor prognosis. British Journal of Cancer (2002) 87, 81–85. doi:10.1038/sj.bjc.6600434 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-07-01 2002-07-15 /pmc/articles/PMC2364278/ /pubmed/12085261 http://dx.doi.org/10.1038/sj.bjc.6600434 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular and Cellular Pathology
Watanabe, J
Sato, H
Kanai, T
Kamata, Y
Jobo, T
Hata, H
Fujisawa, T
Ohno, E
Kameya, T
Kuramoto, H
Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
title Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
title_full Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
title_fullStr Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
title_full_unstemmed Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
title_short Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
title_sort paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters
topic Molecular and Cellular Pathology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364278/
https://www.ncbi.nlm.nih.gov/pubmed/12085261
http://dx.doi.org/10.1038/sj.bjc.6600434
work_keys_str_mv AT watanabej paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT satoh paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT kanait paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT kamatay paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT jobot paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT hatah paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT fujisawat paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT ohnoe paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT kameyat paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters
AT kuramotoh paradoxicalexpressionofcellcycleinhibitorp27inendometrioidadenocarcinomaoftheuterinecorpuscorrelationwithproliferationandclinicopathologicalparameters